You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 62 No. 3, March 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correction
 This Article
 •PDF of this Correction
 •Original article
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on ISI (5)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Pramipexole vs Levodopa as Initial Treatment for Parkinson Disease: A 4-Year Randomized Controlled Trial—Correction

Arch Neurol. 2005;62:430.

Error in Figure. In Figure 3 of the article titled "Pramipexole vs Levodopa as Initial Treatment for Parkinson Disease: A 4-Year Randomized Controlled Trial," published in the July issue of the ARCHIVES (2004;61:1044-1053), the lines indicating mean change in Unified Parkinson’s Disease Rating Scale activities of daily living scores during pramipexole and levodopa treatments should be reversed. The top line should indicate pramipexole, and the bottom line should indicate levodopa.







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.